February 2023
- Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer’s Disease in an Observational Cohort Study
- Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
- Association of COVID-19 with New-Onset Alzheimer’s Disease
- A 19-Year-Old Adolescent with Probable Alzheimer’s Disease
- Aluminum and Amyloid-β in Familial Alzheimer’s Disease
- Is Caffeine a Cognitive Enhancer?
- Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
- Caffeine, Mental Health, and Psychiatric Disorders
- Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
- Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
January 2023
- Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
- Association of COVID-19 with New-Onset Alzheimer’s Disease
- Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer’s Disease in an Observational Cohort Study
- Handgrip Strength Is Related to Hippocampal and Lobar Brain Volumes in a Cohort of Cognitively Impaired Older Adults with Confirmed Amyloid Burden
- Exposure to World Trade Center Dust Exacerbates Cognitive Impairment and Evokes a Central and Peripheral Pro-Inflammatory Transcriptional Profile in an Animal Model of Alzheimer’s Disease
- Is Caffeine a Cognitive Enhancer?
- Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
- Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer’s Disease: A Randomized Clinical Trial
- Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
- Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
December 2022
- Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
- Association of COVID-19 with New-Onset Alzheimer’s Disease
- Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
- Is Caffeine a Cognitive Enhancer?
- Is the Frontal Lobe the Primary Target of SARS-CoV-2?
- Handgrip Strength Is Related to Hippocampal and Lobar Brain Volumes in a Cohort of Cognitively Impaired Older Adults with Confirmed Amyloid Burden
- It’s Groundhog Day! What Can the History of Science Say About the Crisis in Alzheimer’s Disease Research?
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
- Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
November 2022
- Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
- Association of COVID-19 with New-Onset Alzheimer’s Disease
- Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
- Is Caffeine a Cognitive Enhancer?
- Caffeine, Mental Health, and Psychiatric Disorders
- Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
- COVID-19 as a Risk Factor for Alzheimer’s Disease
- Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands
October 2022
- Association of COVID-19 with New-Onset Alzheimer’s Disease
- Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
- Is Caffeine a Cognitive Enhancer?
- Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
- Nationally Informed Recommendations on Approaching the Detection, Assessment, and Management of Mild Cognitive Impairment
- Brain Tissue-Derived Extracellular Vesicles in Alzheimer’s Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers
- Caffeine, Mental Health, and Psychiatric Disorders
- Caffeine and Adenosine
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
September 2022
- Association of COVID-19 with New-Onset Alzheimer’s Disease
- Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
- Is Caffeine a Cognitive Enhancer?
- Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
- Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial
- Caffeine, Mental Health, and Psychiatric Disorders
- Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study
- Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
- COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
- Nationally Informed Recommendations on Approaching the Detection, Assessment, and Management of Mild Cognitive Impairment
August 2022
- Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
- Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
- Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
- COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
- Is Caffeine a Cognitive Enhancer?
- Potential Involvement of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1
- Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial
- The Dark Side of Alzheimer’s Disease: Neglected Physiological Biomarkers of Brain Hyperexcitability and Abnormal Consciousness Level
- Air Pollution and Dementia: A Systematic Review
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
July 2022
- Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
- Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
- Automated Early Detection of Alzheimer’s Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks
- Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging
- COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
- Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
- Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
- Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions
- Air Pollution and Dementia: A Systematic Review
June 2022
- Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching
- Spiritual Fitness: A New Dimension in Alzheimer’s Disease Prevention
- Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
- Is Caffeine a Cognitive Enhancer?
- Caffeine and Adenosine
- COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
- Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis
- A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer’s Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging
- Caffeine, Mental Health, and Psychiatric Disorders
May 2022
- Is Caffeine a Cognitive Enhancer?
- Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
- Caffeine, Mental Health, and Psychiatric Disorders
- Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands
- Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
- Caffeine and Adenosine
- Neurobiology of COVID-19
- Impact of Social Isolation on People with Dementia and Their Family Caregivers
- Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis
April 2022
- Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
- Is Caffeine a Cognitive Enhancer?
- Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
- Caffeine and Adenosine
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
- Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
- Making the Case for Accelerated Withdrawal of Aducanumab
- Caffeine, Mental Health, and Psychiatric Disorders
- Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands
- Neurobiology of COVID-19
March 2022
- Is Caffeine a Cognitive Enhancer?
- Stress, Meditation, and Alzheimer’s Disease Prevention: Where The Evidence Stands
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
- Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer’s Disease: A Randomized Controlled Trial
- Caffeine and Adenosine
- Caffeine, Mental Health, and Psychiatric Disorders
- Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis
- Spiritual Fitness: A New Dimension in Alzheimer’s Disease Prevention
- Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early AD
- Cognitive Effects of Aerobic Exercise in Alzheimer’s Disease: A Pilot Randomized Controlled Trial